An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
SATURDAY 7th MAY 2016
Case 1 Hormonal Therapy
Moderator : Dr. T Raja
Case 2: Neoadjuvant Therapy
Moderator : Dr. Madhuchanda Kar
Debate 2: That regional nodal radiotherapy is required in all early stage node + ve Breast Cancer
Moderator : Dr. Prasenjit Chatterjee
Case 3: Targeted Therapy Sequencing
Speaker : Dr. B.K. Smruti
Moderator : Dr. Sharadwat Mukhopadhyay, Dr. Amit Kumar, Dr. Abhishek Basu, Dr. P N Mohapatra, Dr. Santa Ayyagri, Dr. Naresh Somani, Dr. Subroto Saha
Debate 3: Should surgery be offered for loco regional control in Metastatic breast cancer
Moderator : Dr. Arunabha Sengupta
Case 4: Endocrine Resistance
Moderator : Dr. Dinesh Pendharkar
Debate 4: That targeted therapy and endocrine treatment should be combined upfront before endocrine resistance develops
Moderator : Dr. Sharadwat Mukhopadhyay
Case 5: TNBC
Moderator : Dr. Ullas Batra
Debate 5: That all TNBC should receive a platinum agent in adjuvant settings
Moderator : Dr. Rakesh Roy
Panel Discussion: Paradigm Shift In Management of Her 2 Positive Early Breast Cancer
Moderator : Dr. Sharadwat Mukhopadhyay
Role of Cyclin-Dependent Kinase 4/6 inhibitors in Endocrine Therapy for Metastatic Breast Cancer
Speaker : Dr. Chanchal Goswami
Panel Discussion: Understanding place of CDK 4/6 inhibitors in Indian treatment landscape
Moderator : Dr. Chanchal Goswami
Development of Vivitra
Speaker : Dr. Sanjeev Kumar
Panel Discussion: How Comfortable Are Doctors Using Biosimilar Trastuzumab?
Moderator : Dr. Amit Dutt Dwary